Express Scripts Offers Diabetes Patients a $25 Cap for Monthly Insulin

By Katie Thomas
NYT Health
Drug makers, insurers and pharmacy benefit managers face mounting pressure from Congress and the public to reduce the high list prices of drugs like insulin.
Published date: April 3, 2019 at 01:30PM
The New York Times
New York Times article